Time course of endothelial dysfunction markers and mortality in COVID‐19 patients: A pilot study
Open Access
- 1 March 2021
- journal article
- letter
- Published by Wiley in Clinical and Translational Medicine
- Vol. 11 (3), e283
- https://doi.org/10.1002/ctm2.283
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- COVID-19 is, in the end, an endothelial diseaseEuropean Heart Journal, 2020
- Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19–Associated CoagulopathyCirculation, 2020
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19The New England Journal of Medicine, 2020
- COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular ResearchesGeroScience, 2020
- Severe COVID-19 infection associated with endothelial activationThrombosis Research, 2020
- C-reactive protein levels in the early stage of COVID-19Medecine Et Maladies Infectieuses, 2020
- Epidemiology and treatment of pulmonary arterial hypertensionNature Reviews Cardiology, 2017
- Endothelin-1 and Angiogenesis in CancerCurrent Vascular Pharmacology, 2005
- Modulation of Endothelial Cell Expression of ICAM-1, E-Selectin, and VCAM-1 by β-Estradiol, Progesterone, and DexamethasoneCellular Immunology, 1996